Transmyocardial CO2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial
✍ Scribed by John A Spertus; Philip G Jones; Michael Coen; Mukesh Garg; Brent Bliven; James O’Keefe; Robert J March; Keith Horvath
- Book ID
- 117013535
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 150 KB
- Volume
- 111
- Category
- Article
- ISSN
- 1555-7162
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background and Objectives We assessed quality of life (QOL) after XeCl transmyocardial laser revascularization (TMLR). ## Study Design/Materials and Methods Thirty patients were randomized to receive XeCl excimer TMLR or optimal cardiac medication (controls). QOL was assessed at b
## Abstract As part of the first randomized, sham‐timulation controlled trial on deep brain stimulation (DBS) in primary segmental or generalized dystonia, health‐related quality of life (HRQoL) was assessed by SF‐36. After the 3‐month sham‐controlled phase, significant HRQoL improvement occurred o